{"id":22827,"date":"2026-04-30T12:55:31","date_gmt":"2026-04-30T09:55:31","guid":{"rendered":"https:\/\/ovza.com\/?p=22827"},"modified":"2026-05-01T00:02:10","modified_gmt":"2026-04-30T21:02:10","slug":"offshore-spvs-for-medtech-manufacturers","status":"publish","type":"post","link":"https:\/\/ovza.com\/es\/offshore-spvs-for-medtech-manufacturers\/","title":{"rendered":"Offshore SPVs for MedTech Manufacturers"},"content":{"rendered":"<section class=\"l-section wpb_row us_custom_f05bea1e height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-html\"><!DOCTYPE html>\n<html lang=\"en\">\n<head>\n    <meta charset=\"UTF-8\">\n    <meta name=\"viewport\" content=\"width=device-width, initial-scale=1.0\">\n     <style>\n        .audio-container {\n            background-color: #f0f2f5;\n            border: 1px solid #e0e0e0;\n            border-radius: 10px;\n            box-shadow: 0 4px 8px #fff;\n            padding: 20px;\n            width: 100%;\n            max-width: 100%;\n            box-sizing: border-box;\n        }\n\n        audio {\n            width: 100%;\n            outline: none;\n        }\n\n        .audio-header {\n            display: flex;\n            align-items: center;\n            margin-top: 0px !important;\n            padding-left: 2rem;\n        }\n\n        .audio-icon {\n            background-color: #1db38d;\n            border-radius: 50%;\n            width: 45px;\n            height: 45px;\n            display: flex;\n            align-items: center;\n            justify-content: center;\n            margin-right: 10px;\n        }\n\n        .audio-icon svg {\n            width: 24px;\n            height: 24px;\n            fill: #fff !important; \/* White icon color *\/\n        }\n\n        .audio-title {\n            font-weight: normal;\n            color: #000;\n            font-size: 18px;\n        }\n\n        \/* Media query for mobile devices *\/\n         @media (max-width: 600px) {\n     .audio-header {\n                flex-direction: row;\n                justify-content: center; \/* Ensures center alignment *\/\n                text-align: center;\n                width: 100%;\n            }\n\n            .audio-icon {\n                margin-right: 10px;\n                margin-left: -2rem;\n            }\n\n            .audio-title {\n                margin-top: 0;\n            }\n        }\n    <\/style>\n<\/head>\n\n    <div class=\"audio-container\">\n        <audio controls>\n            <source src=\"https:\/\/ovza.com\/wp-content\/uploads\/2026\/04\/Offshore-SPVs-for-MedTech-Manufacturers-2.mp3\" type=\"audio\/mpeg\">\n            \n        <\/audio>\n        <div class=\"audio-header\">\n            <div class=\"audio-icon\">\n                <svg aria-hidden=\"true\" focusable=\"false\" data-prefix=\"fas\" data-icon=\"headphones\"\n                     xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewbox=\"0 0 512 512\">\n                    <path\n                          d=\"M256 32C114.52 32 0 146.496 0 288v48a32 32 0 0 0 17.689 28.622l14.383 7.191C34.083 431.903 83.421 480 144 480h24c13.255 0 24-10.745 24-24V280c0-13.255-10.745-24-24-24h-24c-31.342 0-59.671 12.879-80 33.627V288c0-105.869 86.131-192 192-192s192 86.131 192 192v1.627C427.671 268.879 399.342 256 368 256h-24c-13.255 0-24 10.745-24 24v176c0 13.255 10.745 24 24 24h24c60.579 0 109.917-48.098 111.928-108.187l14.382-7.191A32 32 0 0 0 512 336v-48c0-141.479-114.496-256-256-256z\">\n                    <\/path>\n                <\/svg>\n            <\/div>\n           \n        <\/div>\n    <\/div>\n\n<\/html><\/div><div class=\"w-separator size_small\"><\/div><div class=\"wpb_text_column us_custom_1f257949 postdata\"><div class=\"wpb_wrapper\"><p>For MedTech manufacturers in 2026, value is no longer measured by the unit price of a machine. It is measured by &#8220;Clinical Yield&#8221; the actual diagnostic outcomes and surgical uptime of a global fleet.<\/p>\n<p>As healthcare providers pivot toward Hardware-as-a-Service (HaaS) models to bypass massive CapEx, manufacturers are finding that traditional corporate balance sheets are too rigid to support thousands of leased robotic units. The result is a move toward Special Purpose Vehicles (SPVs) as the standard architecture for the modern MedTech enterprise. By utilizing an offshore SPV, manufacturers are &#8220;siloing&#8221; their high-value hardware to ensure it remains bankable, insurable, and shielded from the parent company&#8217;s operational liabilities.<\/p>\n<h2 id='the-shift-to-outcome-based-architecture'><b>The Shift to Outcome-Based Architecture<\/b><\/h2>\n<p>In the current landscape, a high-density diagnostic hub or surgical robot is a high-stakes asset. We\u2019ve seen the pressure on domestic-only models; as we approach the mid-2026 mandates, companies that keep their hardware on the main balance sheet are struggling with &#8220;Heavy Balance Sheet&#8221; syndrome, which drags down R&amp;D agility.<\/p>\n<p>A correctly structured offshore SPV provides three defining advantages for HaaS-focused firms:<\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Asset-Backed Isolation:<\/b> Separating physical hardware from the parent company\u2019s general liabilities. If a local facility faces a malpractice dispute, the core hardware assets and global patents remain legally untouched.<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Subscription-Ready Treasury:<\/b> Modern HaaS requires massive liquidity for &#8220;Always-On&#8221; updates. Offshore hubs centralize subscription revenue, facilitating 24\/7 autonomous maintenance and software deployment without domestic bureaucratic drag.<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Lifecycle Liquidity:<\/b> These structures allow for seamless &#8220;Secondary Market&#8221; access, where older-generation hardware can be re-homed to emerging markets without the friction of domestic export-control deadlocks.<\/li>\n<\/ul>\n<p>\u201cIn the 2026 economy, your supply chain is either a sovereign fortress or a shared liability. For MedTech providers, the difference between a domestic setup and an offshore SPV is measured in both clinical uptime and protected capital. By decoupling the hardware fleet from the parent company, you ensure that a single malpractice claim or a local regulatory shift cannot freeze your global R&amp;D. The SPV acts as a legal &#8216;circuit breaker,&#8217; allowing the hardware to continue generating subscription revenue and receiving 24\/7 autonomous software updates from a neutral treasury, even if the primary operating entity is embroiled in a domestic dispute. This isn&#8217;t just a tax play, it is a survival architecture for the Hardware-as-a-Service era.\u201d<b> \u2014 Legal Affairs Team, OVZA<\/b><\/p>\n<h2 id='5-reasons-medtech-founders-are-heading-offshore'><b>5 Reasons MedTech Founders are Heading Offshore<\/b><\/h2>\n<ol start=\"1\">\n<li><b> Safeguarding the &#8220;Digital Brain&#8221; of the Technology<\/b><\/li>\n<\/ol>\n<p>Let\u2019s face it, medical technology is a high-stakes, litigious business. But the rise of 2026\u2019s &#8220;Outcome-Based&#8221; contracts has changed the game entirely. Imagine your cutting-edge surgical robot is deployed, but it misses a very specific, pre-agreed clinical benchmark. Under these new rules, the liability and the associated financial risk can land squarely on the manufacturer.<\/p>\n<p>This is why founders are heading offshore. By isolating specific device fleets (say, all the robots in APAC or the entire diagnostic AI infrastructure in the EU) within their own offshore Special Purpose Vehicles (SPVs), they create a crucial &#8220;Legal Circuit Breaker.&#8221; This ensures that a technical failure or a large lawsuit in one region doesn&#8217;t trigger a financial freeze on the bank accounts of the entire global group. It&#8217;s a fundamental move to protect the core business from regional operational shocks.<\/p>\n<ol start=\"2\">\n<li><b> Creating a Legal Firewall Against &#8220;Outcome-Based&#8221; Liability<\/b><\/li>\n<\/ol>\n<p>The software, the AI, the core algorithms, this is the real magic and the most valuable asset of any modern MedTech company. Unfortunately, new 2026 transparency laws, like the demands coming from systems like <a href=\"https:\/\/ec.europa.eu\/tools\/eudamed\/#\/screen\/home\" target=\"_blank\" rel=\"noopener\">EUDAMED<\/a>, are requiring deeper and more aggressive software audits.Founders are using smart, offshore structures to ring-fence and protect their proprietary diagnostic algorithms. By holding the core Intellectual Property (IP) in a jurisdiction known for its incredibly strong statutory data and commercial privacy laws, they can often prevent the forced disclosure of critical &#8220;Model Weights&#8221; or core algorithmic trade secrets during aggressive, sometimes hostile, domestic regulatory audits. It&#8217;s about keeping the secret sauce safe.<\/p>\n<ol start=\"3\">\n<li><b> Streamlining the Path for Tokenized Infrastructure Financing<\/b><\/li>\n<\/ol>\n<p>The way capital is being deployed in 2026 has fundamentally shifted. Instead of trying to fund an entire company with a single, complex equity round, capital providers are increasingly looking to fund specific, tangible Health-as-a-Service (HaaS) fleets meaning they want to finance 100 specific diagnostic machines or a regional cohort of surgical robots.<\/p>\n<p>An offshore SPV makes this &#8220;fractional asset&#8221; investment strategy seamless. It allows the company to attract sophisticated institutional ESG capital investors who are specifically looking for predictable, hardware-backed yields without forcing them to deal with the messy complications and valuation volatility of the parent company&#8217;s broader equity play. It turns complex financing into a clean, asset-based transaction.<\/p>\n<ol start=\"4\">\n<li><b> Bypassing Cross-Border Data Residency Deadlocks<\/b><\/li>\n<\/ol>\n<p>The global regulatory environment under the latest &#8220;Sovereign Health&#8221; mandates has made moving patient data an absolute nightmare. Every nation wants health data to stay within its borders, creating significant operational logjams for global AI companies that need to process diverse inputs.<\/p>\n<p>An offshore structure fundamentally simplifies the management of geographically distributed data nodes. By strategically placing the processing SPV, it ensures that your core diagnostic AI can legally and efficiently process global inputs while maintaining full compliance with the increasingly complex 2026 Interoperability Rules. It turns a compliance bottleneck into an operational advantage.<\/p>\n<ol start=\"5\">\n<li><b> Ensuring a Clean, &#8220;Plug-and-Play&#8221; Exit and M&amp;A Pathways<\/b><\/li>\n<\/ol>\n<p>When a massive global healthcare conglomerate sets its sights on acquiring a promising MedTech startup in 2026, their primary goal is to acquire the &#8220;Verified Uptime&#8221; , the proven, reliable revenue stream from the deployed hardware without inheriting a mountain of compliance red tape from dozens of jurisdictions.This is where the offshore holding company shines. It makes the acquisition process exponentially faster, smoother, and less risky for the buyer. It allows for a clean, almost instant &#8220;plug-and-play&#8221; transfer of the entire deployed hardware fleet and its associated, verifiable revenue streams, maximizing the founder&#8217;s valuation and minimizing the time spent in due diligence.<\/p>\n<h2 id='comparison-domestic-sales-vs-the-offshore-haas-agent'><b>Comparison: Domestic Sales vs. The Offshore HaaS Agent<\/b><\/h2>\n<table>\n<tbody>\n<tr>\n<td>Feature<\/td>\n<td>Legacy Domestic Sales<\/td>\n<td>The Offshore HaaS Agent<\/td>\n<\/tr>\n<tr>\n<td>IP Protection<\/td>\n<td>Public\/Audited Disclosure<\/td>\n<td>Sovereign &amp; Ring-fenced IP<\/td>\n<\/tr>\n<tr>\n<td>Infrastructure<\/td>\n<td>Standard One-time Sales<\/td>\n<td>Dynamic Fleet Management<\/td>\n<\/tr>\n<tr>\n<td>Transaction Logic<\/td>\n<td>Human-initiated (Slow)<\/td>\n<td>Autonomous Subscription (Instant)<\/td>\n<\/tr>\n<tr>\n<td>Market Access<\/td>\n<td>Single-Region Locked<\/td>\n<td>Multi-Jurisdictional Reach<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 id='conclusion'><b>Conclusion<\/b><\/h2>\n<p>The era of &#8220;outright sales&#8221; is effectively over. For the modern MedTech entrepreneur, robotic code and offshore SPVs are essential partners: one provides the clinical intelligence, and the other provides the secure, global framework to monetize it at scale. By structuring your project internationally, you gain the agility and asset security needed to lead the 2026 medical revolution.<\/p>\n<\/div><\/div><div class=\"w-separator size_small\"><\/div><div class=\"g-cols wpb_row us_custom_23d78c9b hide_on_default hide_on_laptops via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_middle type_default stacking_default\" style=\"--gap:3rem;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><h3 class=\"w-text us_custom_c57c2555 has_text_color hide_on_default hide_on_laptops\"><span class=\"w-text-h\"><span class=\"w-text-value\">Preguntas frecuentes<\/span><\/span><\/h3><div class=\"w-tabs us_custom_6a9b8108 style_default switch_click accordion has_scrolling\" style=\"--sections-title-size:inherit\"><div class=\"w-tabs-sections titles-align_none icon_plus cpos_right\"><div class=\"w-tabs-section\" id=\"t225\"><button class=\"w-tabs-section-header\" aria-controls=\"content-t225\" aria-expanded=\"false\"><div class=\"w-tabs-section-title\">Can an offshore SPV hold our software licenses and hardware titles?<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content\" id=\"content-t225\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"wpb_text_column us_custom_07051a4e\"><div class=\"wpb_wrapper\"><p><span style=\"font-weight: 400;\">Yes. In 2026, it is common for the SPV to own the physical hardware and a sub-license for the software, making it easier for the device to &#8220;self-finance&#8221; its own maintenance and upgrade cycles.<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div><div class=\"w-tabs-section\" id=\"j38b\"><button class=\"w-tabs-section-header\" aria-controls=\"content-j38b\" aria-expanded=\"false\"><div class=\"w-tabs-section-title\">How does this structure protect against &#8220;Malpractice Liability&#8220; lawsuits?<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content\" id=\"content-j38b\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"wpb_text_column us_custom_07051a4e\"><div class=\"wpb_wrapper\"><p><span style=\"font-weight: 400;\">By isolating specific hardware fleets within their own SPVs, you limit the legal &#8220;blast radius.&#8221; If a specific robot is involved in a dispute, the parent company&#8217;s core R&amp;D assets and patents remain shielded behind a separate legal personality.<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div><div class=\"w-tabs-section\" id=\"l4d4\"><button class=\"w-tabs-section-header\" aria-controls=\"content-l4d4\" aria-expanded=\"false\"><div class=\"w-tabs-section-title\">Is this only for &#8220;Robotic Surgery&#8220; or &#8220;Imaging&#8220; firms?<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content\" id=\"content-l4d4\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"wpb_text_column us_custom_07051a4e\"><div class=\"wpb_wrapper\"><p><span style=\"font-weight: 400;\">No. Any MedTech startup using an Outcome-Based model (where the hospital pays for successful scans or surgeries) benefits from the high-speed, neutral settlement environment of an offshore hub.<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div><div class=\"w-tabs-section\" id=\"w60d\"><button class=\"w-tabs-section-header\" aria-controls=\"content-w60d\" aria-expanded=\"false\"><div class=\"w-tabs-section-title\">How does an offshore structure protect my &#8220;Diagnostic Data&#8220; and IP?<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content\" id=\"content-w60d\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"wpb_text_column us_custom_07051a4e\"><div class=\"wpb_wrapper\"><p><span style=\"font-weight: 400;\">In 2026, your trained algorithms are your most valuable asset. By holding your core IP in an offshore &#8220;Vault&#8221; entity, you ensure your code is not subject to sudden domestic &#8220;kill-switch&#8221; regulations or seizure during a local legal dispute.<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div><div class=\"w-tabs-section\" id=\"c740\"><button class=\"w-tabs-section-header\" aria-controls=\"content-c740\" aria-expanded=\"false\"><div class=\"w-tabs-section-title\">Is it hard to get a bank account for a HaaS-driven business?<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content\" id=\"content-c740\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"wpb_text_column us_custom_07051a4e\"><div class=\"wpb_wrapper\"><p><span style=\"font-weight: 400;\">Traditional banks struggle with automated subscription flows. In 2026, the solution is pairing your offshore entity with a Specialized MedTech-Native EMI built for international HaaS payments and 24\/7 autonomous settlement.<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row hide_on_tablets hide_on_mobiles height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1-4-1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><h3 class=\"w-text us_custom_c57c2555 has_text_color\"><span class=\"w-text-h\"><span class=\"w-text-value\">Preguntas frecuentes<\/span><\/span><\/h3><div class=\"w-tabs us_custom_57af4b14 style_default switch_click accordion has_scrolling\" style=\"--sections-title-size:inherit\"><div class=\"w-tabs-sections titles-align_none icon_plus cpos_right\"><div class=\"w-tabs-section\" id=\"n7dc\"><button class=\"w-tabs-section-header\" aria-controls=\"content-n7dc\" aria-expanded=\"false\"><div class=\"w-tabs-section-title\">Can an offshore SPV hold our software licenses and hardware titles?<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content\" id=\"content-n7dc\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"wpb_text_column us_custom_07051a4e\"><div class=\"wpb_wrapper\"><p><span style=\"font-weight: 400;\">Yes. In 2026, it is common for the SPV to own the physical hardware and a sub-license for the software, making it easier for the device to &#8220;self-finance&#8221; its own maintenance and upgrade cycles.<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div><div class=\"w-tabs-section\" id=\"n944\"><button class=\"w-tabs-section-header\" aria-controls=\"content-n944\" aria-expanded=\"false\"><div class=\"w-tabs-section-title\">How does this structure protect against &#8220;Malpractice Liability&#8220; lawsuits?<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content\" id=\"content-n944\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"wpb_text_column us_custom_07051a4e\"><div class=\"wpb_wrapper\"><p><span style=\"font-weight: 400;\">By isolating specific hardware fleets within their own SPVs, you limit the legal &#8220;blast radius.&#8221; If a specific robot is involved in a dispute, the parent company&#8217;s core R&amp;D assets and patents remain shielded behind a separate legal personality.<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div><div class=\"w-tabs-section\" id=\"ga85\"><button class=\"w-tabs-section-header\" aria-controls=\"content-ga85\" aria-expanded=\"false\"><div class=\"w-tabs-section-title\">Is this only for &#8220;Robotic Surgery&#8220; or &#8220;Imaging&#8220; firms?<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content\" id=\"content-ga85\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"wpb_text_column us_custom_07051a4e\"><div class=\"wpb_wrapper\"><p><span style=\"font-weight: 400;\">No. Any MedTech startup using an Outcome-Based model (where the hospital pays for successful scans or surgeries) benefits from the high-speed, neutral settlement environment of an offshore hub.<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div><div class=\"w-tabs-section\" id=\"fbe9\"><button class=\"w-tabs-section-header\" aria-controls=\"content-fbe9\" aria-expanded=\"false\"><div class=\"w-tabs-section-title\">How does an offshore structure protect my &#8220;Diagnostic Data&#8220; and IP?<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content\" id=\"content-fbe9\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"wpb_text_column us_custom_07051a4e\"><div class=\"wpb_wrapper\"><p><span style=\"font-weight: 400;\">In 2026, your trained algorithms are your most valuable asset. By holding your core IP in an offshore &#8220;Vault&#8221; entity, you ensure your code is not subject to sudden domestic &#8220;kill-switch&#8221; regulations or seizure during a local legal dispute.<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div><div class=\"w-tabs-section\" id=\"ad1e\"><button class=\"w-tabs-section-header\" aria-controls=\"content-ad1e\" aria-expanded=\"false\"><div class=\"w-tabs-section-title\">Is it hard to get a bank account for a HaaS-driven business?<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content\" id=\"content-ad1e\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"wpb_text_column us_custom_07051a4e\"><div class=\"wpb_wrapper\"><p><span style=\"font-weight: 400;\">Traditional banks struggle with automated subscription flows. In 2026, the solution is pairing your offshore entity with a Specialized MedTech-Native EMI built for international HaaS payments and 24\/7 autonomous settlement.<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-html\"><style>\n.postdata h1, .postdata h2, .postdata h3, .postdata h4, .postdata h5, .postdata h6{\ncolor:#1db38d!important;\nfont-size:x-large;}\n<\/style><\/div><div class=\"wpb_text_column us_custom_e3e7975b\"><div class=\"wpb_wrapper\"><p data-pm-slice=\"1 1 &#091;&#093;\"><em><span style=\"font-weight: 550;\">Disclaimer:<\/span> The information provided on this website is intended for general reference and educational purposes only. While OVZA makes every effort to ensure accuracy and timeliness, the content should not be considered legal, financial, or tax advice.<\/em><\/p>\n<\/div><\/div><div class=\"w-text us_custom_f88b33b2\"><span class=\"w-text-h\"><span class=\"w-text-value\">Share this article<\/span><\/span><\/div><div class=\"w-socials us_custom_165216c9 fixicons color_brand shape_circle style_outlined hover_slide\" style=\"--gap:0.25em;\"><div class=\"w-socials-list\"><div class=\"w-socials-item facebook\"><a href=\"https:\/\/www.facebook.com\/sharer\/sharer.php?u=https:\/\/ovza.com\/offshore-entities-and-international-trade-law\" class=\"w-socials-item-link\" title=\"Facebook\" aria-label=\"Facebook\"><span class=\"w-socials-item-link-hover\"><\/span><i class=\"fab fa-facebook\"><\/i><\/a><\/div><div class=\"w-socials-item twitter\"><a target=\"_blank\" href=\"https:\/\/twitter.com\/intent\/tweet?url=https:\/\/ovza.com\/offshore-entities-and-international-trade-law\" class=\"w-socials-item-link\" title=\"Gorjeo\" aria-label=\"Gorjeo\"><span class=\"w-socials-item-link-hover\"><\/span><i class=\"fab fa-x-twitter\"><svg style=\"width:1em; margin-bottom:-.1em;\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewbox=\"0 0 512 512\"><path fill=\"currentColor\" d=\"M389.2 48h70.6L305.6 224.2 487 464H345L233.7 318.6 106.5 464H35.8L200.7 275.5 26.8 48H172.4L272.9 180.9 389.2 48zM364.4 421.8h39.1L151.1 88h-42L364.4 421.8z\"\/><\/svg><\/i><\/a><\/div><div class=\"w-socials-item linkedin\"><a href=\"https:\/\/www.linkedin.com\/shareArticle?mini=true&amp;url=https:\/\/ovza.com\/offshore-entities-and-international-trade-law\" class=\"w-socials-item-link\" title=\"LinkedIn\" aria-label=\"LinkedIn\"><span class=\"w-socials-item-link-hover\"><\/span><i class=\"fab fa-linkedin\"><\/i><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>","protected":false},"excerpt":{"rendered":"For MedTech manufacturers in 2026, value is no longer measured by the unit price of a machine. It is measured by &#8220;Clinical Yield&#8221; the actual diagnostic outcomes and surgical uptime of a global fleet. As healthcare providers pivot toward Hardware-as-a-Service (HaaS) models to bypass massive CapEx, manufacturers are finding that traditional corporate balance sheets are...","protected":false},"author":2,"featured_media":22822,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[126],"tags":[],"class_list":["post-22827","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles-and-industry"],"acf":[],"_links":{"self":[{"href":"https:\/\/ovza.com\/es\/wp-json\/wp\/v2\/posts\/22827","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ovza.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ovza.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ovza.com\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ovza.com\/es\/wp-json\/wp\/v2\/comments?post=22827"}],"version-history":[{"count":10,"href":"https:\/\/ovza.com\/es\/wp-json\/wp\/v2\/posts\/22827\/revisions"}],"predecessor-version":[{"id":22839,"href":"https:\/\/ovza.com\/es\/wp-json\/wp\/v2\/posts\/22827\/revisions\/22839"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ovza.com\/es\/wp-json\/wp\/v2\/media\/22822"}],"wp:attachment":[{"href":"https:\/\/ovza.com\/es\/wp-json\/wp\/v2\/media?parent=22827"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ovza.com\/es\/wp-json\/wp\/v2\/categories?post=22827"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ovza.com\/es\/wp-json\/wp\/v2\/tags?post=22827"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}